wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35168766-88CD414E-9D8C-4F4E-BF03-CBB89C000223
Q35168766-88CD414E-9D8C-4F4E-BF03-CBB89C000223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35168766-88CD414E-9D8C-4F4E-BF03-CBB89C000223
Overall response rate, progression-free survival, and overall survival with targeted and standard therapies in advanced non-small-cell lung cancer: US Food and Drug Administration trial-level and patient-level analyses.
P2860
Q35168766-88CD414E-9D8C-4F4E-BF03-CBB89C000223
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35168766-88CD414E-9D8C-4F4E-BF03-CBB89C000223
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8eb5a259381b96d1c3b87e494276fbaf2c8a69d9
P2860
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.